Syneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries in North America, Europe, the Middle East and Africa, Asia-Pacific, and Latin America. The company is headquartered in Raleigh, North Carolina.
| Revenue (TTM) | $243.12M |
| Gross Profit (TTM) | $40.61M |
| EBITDA | $-80.62M |
| Operating Margin | 0.00% |
| Return on Equity | -16.70% |
| Return on Assets | -7.74% |
| Revenue/Share (TTM) | $4.83 |
| Book Value | $7.59 |
| Price-to-Book | 0.30 |
| Price-to-Sales (TTM) | 0.49 |
| EV/Revenue | 1.065 |
| EV/EBITDA | 5.29 |
| Quarterly Earnings Growth (YoY) | -84.70% |
| Quarterly Revenue Growth (YoY) | 3.40% |
| Shares Outstanding | $54.68M |
| Float | $38.96M |
| % Insiders | 26.05% |
| % Institutions | 1.34% |